Substantially improved in vivo radiosensitization of rat glioma with mutant HSV-TK and acyclovir

Cancer Gene Therapy

Volumn 8, Issue 1, 2001, Pages 3-8

  Valerie, K ^a   Hawkins, W ^a   Farnsworth, J ^a   Schmidt Ullrich, R ^a   Lin, P S ^a   Amir, C ^a   Feden, J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenovirus; Gene therapy; Ionizing radiation

Indexed keywords

ACICLOVIR; MUTANT PROTEIN; THYMIDINE KINASE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GLIOMA; HERPES SIMPLEX VIRUS; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIZATION; RAT;

ADENOVIRIDAE; ANIMALIA; HERPES; SIMPLEXVIRUS;

EID: 0035121644     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700265     Document Type: Article

References (23)

1. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo
2. Adenovirus-mediated gene therapy of experimental gliomas
3. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: A phase I trial
4. In situ gene therapy for adenocarcinoma of the prostate: A phase I clinical trial
5. Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV-tk gene
6. Preferential radiosensitization of 9L glioma cells transduced with HSV- tk gene by acyclovir
7. Radiosensitization of rat glioma with bromodeoxycytidine and adenovirus expressing HSV-TK delivered by slow positive pressure infusion
8. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant HSV-TK in combination with acyclovir
9. Creation of drug-specific herpes simplex vires type 1 thymidine kinase mutants for gene therapy
10. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
11. Host-cell reactivation of reporter genes introduced into cells by adenovirus as a convenient way to measure cellular DNA repair
12. Viral vectors for gene therapy
13. The assumptions underlying the analysis of variance
14. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy
15. Characterization of the antitumor immune response generated by treatment of murine tumors with recombinant adenoviruses expressing HSVtk, IL-2, IL-6 or B7-1
16. Pronounced antitumor effects and tumor radiosensitization of double suicide gene therapy
17. Double suicide gene therapy augments the antitumor activity of a replication-competent lyric adenovirus through enhanced cytotoxicity and radiosensitization
18. Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer
19. 9- ([2-Hydroxy-1- (hydroxymethyl) ethoxy]methyl)guanine: A selective inhibitor of herpes group virus replication
20. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2′- deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2
21. Enhanced delivery of ganciclovir to the brain through the use of redox targeting
22. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials